Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPRI-424 Contraceptive Efficacy and Safety Trial
NCT03945513Phase 3Completed
- Sponsor
- Insud Pharma
- Start
- Dec 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dienogest and ethinyl estradiol in contraception, sponsored by Insud Pharma. Primary endpoint: Number of pregnancies (evaluable cycles) up to 13 months. Started Dec 2019; status: completed.
02
Drugs
dienogestethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03945513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03945513.